Hepatitis B Virus X Protein Partially Substitutes for E1A Transcriptional Function during Adenovirus Infection  by SCHAACK, JEROME et al.
VIROLOGY 216, 425–430 (1996)
ARTICLE NO. 0079
SHORT COMMUNICATION
Hepatitis B Virus X Protein Partially Substitutes for E1A Transcriptional
Function during Adenovirus Infection
JEROME SCHAACK, HUGH F. MAGUIRE, and ALEEM SIDDIQUI1
Department of Microbiology, Program in Molecular Biology, University of Colorado Health Sciences Center,
B 172, 4200 East 9th Avenue, Denver, Colorado 80262
Received August 15, 1995; accepted December 8, 1995
Lack of an in vitro culture system for human hepatitis B virus has hampered the ability to address fundamental questions
regarding the viral life cycle and the effect of viral gene products during productive infection. To study the activity of HBV X
protein (HBx) in the context of a viral infectious cycle, we provided HBx in trans during adenovirus infection of liver-derived cells.
In hepatoma cells infected with adenovirus mutants deficient in expression of various E1A products, HBx was able to partially
substitute for the transcriptional activation function of E1A. HBx also activated adenovirus replication, but to a lesser extent than
the activation of transcription. Adenovirus genes transcribed by either RNA polymerase II or RNA polymerase III were activated
by HBx during infection. These results suggest that HBx and E1A activate transcription by a similar mechanism and that this
viral infection system will be useful for characterization of the functional activities of HBx. q 1996 Academic Press, Inc.
Many DNA viruses, including adenovirus and HBV, en- E1A can activate transcription through many different
code proteins that increase the expression of viral genes transcription factors (30; reviewed in references 4 and 9 )
as well as certain host genes (reviewed in reference 9 ). in a manner that appears to be dependent on appropriate
The mechanism(s) of action of these proteins, particularly chromatin domain formation (34 ). While many proposals
the adenovirus E1A protein, has been studied in great for the mechanism by which E1A activates transcription
detail. It is clear that at least some of these proteins have been put forth, one proposal which has gained
are transcriptional activators but the precise mechanism considerable support is that E1A accelerates the rate
remains poorly understood. It is likely that a similar of stable transcription complex formation (1, 11, 24 ). In
mechanism is employed by at least some of the tran- contrast, evidence that E1A activates transcription from
scriptional activator proteins, as indicated by the fact that certain promoters only after stable binding of transcrip-
the pseudorabies virus immediate early protein (8, 19 ) tion components has been presented (33, 35 ).
and the HSV-1 ICP4 gene product (40, 44 ) can both sub- The 17.5-kDa product of the HBV X gene (HBx) posi-
stitute for E1A protein in the activation of certain adenovi- tively regulates expression of HBV genes, most dramati-
rus promoters (reviewed in reference 43 ). cally through nucleotide sequences defined by functional
The E1A gene of adenovirus encodes two related pro- analyses of the HBV enhancer element. A broad range
teins synthesized from the two major, differentially of viral and cellular promoters that direct transcription by
spliced E1A mRNAs early after infection: the 289R pro-
RNA polymerase II (6, 18, 36, 39, 46, 49, 50 ) and RNA
tein, encoded by the 13S mRNA; and the 243R protein,
polymerase III (2 ) are responsive to HBx. Elevation of
translated from the 12S mRNA, which lacks 46 amino
transcriptional activity coincident with expression of HBxacids present in the larger protein. The 289R protein
is not restricted by cell type, implying the involvement oftranscriptionally activates all of the early viral genes, and
ubiquitous transcription factors in HBx-responsive tran-this activity requires its unique 46-amino-acid region (re-
scription. The cAMP-inducible cellular transcription fac-viewed in references 4, 7, and 10 ). Both the 289R and
tors CREB and ATF have been shown to interact withthe 243R proteins stimulate transcription of certain host
HBx, resulting in an increased affinity for specific DNAcell genes (21, 38 ). This stimulation likely involves at
binding sites by these transcription factors (27 ). DNAleast two distinct mechanisms (21 ) since certain genes
sequence elements capable of binding the NF-k B pro-are only activated by the 289R protein while others are
tein also are responsive to activation by HBx (36, 45 ).activated by both the 289R and the 243R proteins.
An increasing number of presumptive cellular targets
of HBx have been reported. These include members of1 To whom correspondence and reprint requests should be ad-
dressed. basal transcription complexes: TBP, TFIIH, TFIIE,
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UVDDB, and RBP5 (5, 25, 31, 32 ). Several reports have
suggested that HBx could transactivate via signal trans-
duction pathways (7, 22, 29 ). More specifically, the Ras,
Raf, and MAP kinase signaling cascade was shown to
be influenced by the presence of HBx in cells. A kunitz-
like domain has been identified in HBx (42 ).
The lack of an infectious tissue culture system has
precluded a detailed characterization of HBx function
during productive infection. Transient transfection
assays have been used to study transactivation by viral
gene products. Given that neither the substrate(s) for,
nor the rate-limiting step(s) in, transcriptional activation is
known, it is not clear that transient transfection systems
accurately reproduce transcriptional activation, as it oc-
curs during viral infection. Thus, it is important to exam-
ine the effects of transactivators during infection. We
have taken advantage of the well-defined tissue culture
system of adenovirus infection to study the role of HBx
in the activation of viral genes during productive infec-
tion. The contributions of HBx, provided in trans, were FIG. 1. RNase protection assays. (A) RNase protection analysis of
compared to those of E1A in allowing adenovirus to pro- HBx mRNA from GET cells (indicated by G above the lane). (B) E1A
mutants and RNase protection assays. The E1 region and mutant vi-ceed through a lytic cycle in liver-derived cell lines. Liver
ruses are presented schematically. The antisense probe transcript forrepresents the major site of infection by HBV and a sec-
E1A and E1B, which extends from base pair 1838 to the left end of theondary site of infection by adenovirus in immunocom-
viral chromosome, is indicated above. The regions of the wild-type E1A
promized patients (41 ). This comparison was extended and E1B mRNAs which overlap the probe are indicated in the middle
using adenovirus deletion mutants which are unable to with the nucleotide numbers of the first and last bases remaining within
the regions of the 12S and 13S mRNAs presented. The deleted regionsproduce specific E1A gene products. HBx partially substi-
of the mutant viruses are indicated by closed boxes below, with thetuted for E1A in activating transcription from adenovirus
nucleotides adjacent to the deleted regions indicated. The sizes ofearly region promoters and permitted a low level of viral
probes for, and protected fragments of, other mRNAs are E2A probe,
DNA replication. 1306 bases, protected fragment, 492 bases; E3 probe, approximately
The ability of HBx to substitute for E1A in transcrip- 633 bases, protected fragments, approximately 615 and 400 bases;
and E4 probe, 1007 bases, protected fragment, 291 bases. Cytoplasmictional activation during infection by adenovirus was ex-
RNA was isolated by lysing cells in hypotonic buffer (10 mM Tris–HCl,amined as a function of the presence of the 289R and
pH 8.0, 10 mM NaCl, 3 mM MgCl2 ) containing 0.5% NP-40, removing243R E1A proteins. GET cells, a polyclonal cell line that
nuclei by centrifugation, and deporteinizing by digesting with 100 mg/
expresses HBx (Fig. 1A) under the control of its own ml proteinase K at 377 for 30 min followed by phenol extraction and
promoter (37 ), and HepG2 cells, derived from a human ethanol precipitation. Cytoplasmic RNA was analyzed by RNase protec-
tion (28 ) using labeled antinsense HBx RNA. Probes were used inhepatoblastoma negative for HBV sequences (23 ) and
sufficient excess to saturate binding as demonstrated by both titrationthe parent of GET cells, were infected with the phenotypi-
of the probe and determination of the relative level of RNase-sensitivecally wild-type virus dl309 (20 ) or with E1A mutants dl348
label from the probe.
which expresses only the E1A 289R protein (48 ), dl347
which expresses only the E1A 243R protein (48 ), or dl343
which expresses neither E1A protein (16; dl343 ex- of HBx or could indicate a direct or indirect interaction
between HBx and E1A.presses a partial E1A protein and minimal E1A function
during the late phase of the infection only (Schaack et The E1A 243R protein did not affect transactivation in
either the presence or the absence of HBx (Fig. 2, com-al., manuscript in preparation); dl343 was used in these
experiments because it is E1A0 prior to the onset of pare H and G lanes from cells infected with dl347 or
dl343). Since transactivation was dependent only on HBxreplication and it encodes an E1A transcript that can be
monitored) (Fig. 1B). Increased accumulation of mRNA and the E1A 289R protein, dl309 and dl343 were used in
subsequent analyses of transcription.from the E1A, E1B, E2A, and E3 genes was observed in
the presence of HBx (Fig. 2). The level of HBx mRNA was Cytoplasmic accumulation of E1A, E1B, E2A, E3, and
E4 mRNAs was examined at various times after infectionnot changed by E1A (data not shown). The presence of
both HBx and the E1A 289R protein increased accumula- of GET and HepG2 cells (Fig. 3). These mRNAs accumu-
lated most rapidly in the presence of both HBx and E1A.tion of each of these by mRNAs in a synergistic manner
6 hr after infection (Fig. 2, compare H and G lanes from Accumulation was nearly maximal after 12 hr in the pres-
ence of E1A (data not shown). In the presence of HBxcells infected with dl309 or dl348). This synergism may
simply reflect increased E1A expression in the presence alone, near-maximal levels were attained between 12
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complexes were attained rather than functioning as an
essential transcription factor.
Equivalent amounts of viral DNA reached the nuclei
of HepG2 and GET cells during the infections and the
ratio of nuclear to cytoplasmic E1A mRNA accumula-
tion was similar in HepG2 and GET cells (data not
shown), suggesting that the effects of HBx occurred at
the level of transcription. To test this, transcription run-
on analyses (15, 17 ) were performed using nuclei iso-
lated from HepG2 and GET cells 6 hr (Fig. 4) and 12
hr (data not shown) after infection with dl309 or dl343.
Incorporation was greatest in the presence of both E1A
and HBx. All of the dl343 early region genes showed
increased incorporation in GET cells relative to HepG2
cells, although the ratio of the level of incorporation
varied and was generally less than a factor of 2. The
increase in incorporation in GET cells infected with
dl343 demonstrates that HBx activated transcription of
the adenovirus early region genes, but the data do not
rule out the possibility of a posttranscriptional effect
of HBx.
Transcriptional activation of adenovirus early region
genes by HBx, as by E1A (30 ), may be mediated by a
variety of factors since there appear to be no transcrip-
tion factor binding sites common to all of the early
region genes (reviewed in references 4 and 9 ). E1A
and HBx likely activate transcription via protein – pro-
tein interactions. E1A interacts specifically with the
general transcription factor TFIID (26 ). HBx enhancesFIG. 2. Transactivation of adenovirus genes by HBx in the presence
and absence of E1A proteins. HepG2 cells (lanes labeled H) and GET the binding of ATF and CREB to the CRE variant se-
cells (lanes labeled G) grown in medium supplemented with 7% fetal quence motif 5* TGACGCAA 3 * found in the HBV en-
calf serum were infected at a multiplicity of 50 plaque-forming units
hancer (27 ). This variant sequence is also found withinper cell with viruses as indicated above each pair of lanes. The viruses
the E3 promoter of adenovirus serotype 5. It is possiblewere grown and titered using 293 cells, a human embryonic kidney
that HBx and E1A act to increase the affinity of bindingcell line transformed by and expressing the E1 region of Ad5 (14 ). Six
hours after infection, the cells were harvested. Cytoplasmic RNA was to the variant site as a means for mediating transcrip-
prepared as in Fig. 1. E1A and E1B mRNAs (panel A) were analyzed tional activation of the E3 gene. However, the variant
using a probe which overlaps all of E1A and the first 139 bases of the
sequence is not found in any of the other promoterE1B mRNAs. E2A mRNA (panel B) was analyzed using a probe ex-
regions. Further, the similarity in temporal accumula-tending from the BamHI site at 60.0 map units (m.u.) to the BstEII site
tion of the early region mRNAs and the fact that differ-at 63.6 m.u. The E3 mRNAs (panel C) were analyzed using a probe
which extended from the EcoRI site at 83.5 m.u. to the AlwNI site at ent transcription factor binding sites can mediate both
81.7 m.u. The specific protection products of the wild-type virus are E1A (30 ) and HBx activities suggest that the mecha-
indicated. For dl343, the 2-base pair deletion within the 5* exon of E1A
nism of transcriptional activation may have at least(see Fig. 1B) leads to a variable frequency of cleavage. The cleavage
some common features.product of the dl343 13S 5* exon migrates slightly behind the 12S 5*
The effect of HBx on transcription by RNA polymer-exon protected fragment from the wild-type virus and the 12S 5* exon
product migrates in front of the 3* exon protected fragment. In the ase III of the VAI gene during the early phase of infec-
experiment shown, cleavage at the site of deletion within dl343 E1A tion was examined by comparing accumulation of VAI
mRNA was nearly complete.
RNA in GET and HepG2 cells infected with dl343. In
independent experiments, the degree of transactiva-
tion by HBx varied from 0 to approximately 20-fold,and 24 hr, while in the absence of the transcriptional
activators, near-maximal mRNA levels were not achieved with a normal approximately 5-fold activation (Fig. 5)
(a figure considerably lower than that observed in theuntil approximately 24 hr (data not shown). While the time
required for maximal accumulation of viral mRNA varied, presence of E1A), suggesting either that the level of
HBx expressed in GET cells is insufficient to fully acti-the peak concentration was approximately the same in
the absence of transactivators as in the presence of HBx vate VAI transcription or that E1A plays a role that
HBx does not. In transient transfection and in vitrowith or without E1A. Thus, HBx and E1A appeared to
increase the rate at which maximally active transcription transcription assays, HBx increased transcription of
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FIG. 3. Kinetics of transactivation by HBx and E1A. GET cells (lanes labeled G) and HepG2 cells (lanes labeled H) were infected with either dl309
(wild type) or dl343. Cytoplasmic RNA from cells at various times after infection was probed for (A) E1A and E1B, (B) E2A, (C) E3, and (D) E4 mRNAs.
The E4 probe extended from the HindIII site at 89.1 to the SmaI site at 91.9. To the right of A, prolonged exposures of E1A mRNA analysis for times
early after infection are shown. The E1A and E1B bands are from the same exposure. The specific protection products are indicated.
the adenovirus VAI RNA gene by a factor of 20- to 40- when no activation of the VAI gene was apparent (data
not shown). Although differences in the degree of acti-fold (2 ). Notably, we observed significant HBx-depen-
dent activation of transcription by RNA polymerase II vation of genes transcribed by RNA polymerase II were
FIG. 4. Run-on analysis of adenovirus early region genes in GET and HepG2 cells. HepG2 cells were infected with dl309 and GET and HepG2
cells were infected with dl309 or dl343 at a multiplicity of 50 plaque-forming units per cell. After 6 hr, nuclei were isolated and subjected to
transcriptional run-on in the presence of [a-32P]CTP (15, 17 ). The transcripts were purified and hybridized to denatured DNAs immobilized on
nitrocellulose using a slot blot apparatus. The level of incorporation was determined using phosphorimaging and is presented normalized to the
level of incorporation into b-tubulin.
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within 24 hr after infection of HepG2 cells. By 48 hr, dl343
replication in HepG2 cells was approximately half of that
in GET cells. By 72 hr, replication in HepG2 cells was
equivalent to that in GET cells. Thus, HBx served to de-
crease the lag time before replication began, but did not
affect the final yield of dl343 DNA.
In contrast to its effect on dl343 replication, HBx had a
strong effect on replication of dl312 (Fig. 6B). The greater
FIG. 5. Activation of the VAI gene by HBx. GET cells (lanes labeled
ability of dl343 than dl312 to replicate in the absence ofG) and HepG2 cells (lanes labeled H) were infected with dl343. Six
HBx presumably reflects the partial E1A function thathours after infection, the cells were harvested. Cytoplasmic RNA was
analyzed for VAI RNA using an antisense copy of VAI RNA. The specific results from entry of dl343 into the late phase. Given the
protection product is indicated. transcriptional activation of adenovirus genes, including
genes involved in viral replication, by HBx, it is not sur-
prising that replication occurred in an HBx-dependentdetected, these variations were much less than those
manner. The fact that HBx complemented the transcrip-observed for genes transcribed by RNA polymerase III.
tional defect much more efficiently than the replicationThe causes of the variability in activation of the VAI
defect indicates that HBx lacks replication functions thatRNA gene are being examined further.
E1A performs. E1A interacts with cellular factors suchViral DNA replication in cells infected with either the
as Rb (47 ) and the cdc2-associated p60 (12 ) which maywild-type virus dl309 or the E1A0 viruses dl343 (which
influence viral replication through control of expressionexhibits partial E1A function during the late phase of the
of required host proteins. The reduced effect on viralinfection (Schaack et al., manuscript in preparation)) and
replication of HBx may reflect an inability to interact withdl312 (which is completely lacking in E1A function) was
such cellular factors.assayed (Fig. 6). dl309 replicated to approximately 10-
Recent studies by Qadri et al., and those by Maguirefold higher than input levels after 12 hr and approximately
et al., show that HBx can directly interact with TBP and100-fold after 24 hr in both HepG2 and GET cells. Replica-
transcriptional factor ATF-2. The binding to these factorstion continued at a rapid rate beyond 24 hr (data not
is also shared by E1A. The HBx domain that binds toshown). Thus, HBx had little or no effect on viral replica-
TBP consisting of aa 110–143 displays striking resem-tion in the presence of E1A in spite of the increased rate
blance with a domain (aa 125–145) of the E1A proteinof accumulation of viral early region mRNAs encoding
which is identified as the minimal region required forproteins involved in replication. In GET cells infected with
interaction with TBP.dl343, viral DNA replication had not begun by 12 hr,
In summary, the studies presented here demonstratereached 5- to 7-fold input levels by 24 hr, and then oc-
that HBx can partially substitute for E1A transcriptionalcurred at a more rapid rate through 72 hr, after which
activation function during an adenovirus infection. Thetime the cell-associated viral DNA concentration de-
adenovirus infectious system offers promise for the delin-clined (data not shown), presumably due to release of
mature virus. Little or no replication of dl343 occurred eation of the various functions of HBx.
FIG. 6. Viral replication in the presence of HBx or E1A. (A) GET and HepG2 cells were infected with either dl309 or dl343. (B) GET and HepG2
cells were infected with dl312. At various times after infection, cells were harvested and DNA was prepared by digestion with proteinase K, phenol
extraction, and ethanol precipitation. DNA was denatured, applied at various dilutions to nitrocellulose using a slot blot apparatus, and probed with
uniformly 32P-labeled adenovirus DNA. The concentration of adenovirus DNA was determined by liquid scintillation counting of the excised slot and
plotted as a function of time of infection.
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